COLORADO SPRINGS, Colo., Feb. 8 /PRNewswire-FirstCall/ -- Spectranetics Corporation today announced that the company will release 2005 fourth quarter and year end financial results prior to market open on Wednesday, February 22, 2006. Company management will host an investment-community conference call beginning at 10:00 a.m. Mountain Time (Noon Eastern Time) on Wednesday, February 22 to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing (888) 803-8271 for domestic callers, or (706) 634-2467 for international callers, or from the webcast on the investor relations section of the Company's Web site at www.spectranetics.com.
A 48-hour telephone replay will be available approximately one hour after the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers and entering reservation code 5076106. The webcast will be available on the Company's Web site for 14 days following the completion of the call.
About Spectranetics
Spectranetics is a medical device company that develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system. Its CVX-300(R) excimer laser is the only system approved by the FDA for multiple cardiovascular procedures, including coronary atherectomy, and the removal of problematic pacemaker and defibrillator leads. Nearly all of the company's FDA-approved and investigational applications have received Communautes Europeennes (CE) mark registration for marketing within Europe. In April 2004 Spectranetics obtained 510(k) clearance from the FDA for the laser-based treatment of patients suffering from total occlusions (blockages) in their leg arteries that are not crossable with a guide wire.
COMPANY CONTACT: Spectranetics Corporation John Schulte, Chief Executive Officer Guy Childs, Chief Financial Officer (719) 633-8333 INVESTOR & MEDIA CONTACTS: Lippert/Heilshorn & Associates, Inc. Don Markley or Bruce Voss dmarkley@lhai.com (310) 691-7100
Spectranetics CorporationCONTACT: John Schulte, Chief Executive Officer, or Guy Childs, ChiefFinancial Officer, both of Spectranetics Corporation, +1-719-633-8333; orDon Markley, dmarkley@lhai.com, or Bruce Voss, both of Lippert/Heilshorn &Associates, Inc., +1-310-691-7100, for Spectranetics Corporation
Web site: http://www.spectranetics.com/
